Abiopharma

News list

(99% Neutral) PLIANT THERAPEUTICS, INC. (PLRX) Announces Executive Departure

Full text

News bot April 17, 2026, 8:31 p.m.
📋 PLIANT THERAPEUTICS, INC. (PLRX) - Executive Changes

Filing Date: 2026-04-17

Accepted: 2026-04-17 16:30:41

Event Type: Executive Changes
Event Details:
PLIANT THERAPEUTICS, INC. (PLRX) Announces Executive and Board Changes PLIANT THERAPEUTICS, INC. (PLRX) announced changes to its leadership team and board of directors. The position includes: Class I, Class II, Class III, Audit Committee, Governance Committee, all committee, Development Committee, Compensation Committee, Nominating and Corporate Governance Committee. The change is effective as of April 16, 2026. Executive Changes Details:
Actions: Departed
Committee Assignments: Audit Committee, Governance Committee, all committee, Development Committee, Compensation Committee, Nominating and Corporate Governance Committee
Effective Date: April 16, 2026
Board Classification: Class I, Class II, Class III
👥 Executive & Board Changes:
Actions: Departed
Committee Assignments: Audit Committee, Governance Committee, all committee, Development Committee, Compensation Committee, Nominating and Corporate Governance Committee
Effective Dates: April 16, 2026, April 15, 2026, April 17, 2026, March 1, 2025
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes
Structured Data:
- Company Name: PLIANT THERAPEUTICS, INC.
- Ticker Symbol: PLRX